Skip to main content
Premium Trial:

Request an Annual Quote

Skyline Dx, Janssen Partner on Companion Dx Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dutch array-based diagnostics firm Skyline Diagnostics today announced a deal with Janssen Pharmaceutica for the analysis of an undisclosed marketed compound.

Under the terms of the deal, Skyline will use its expertise and technologies in genetic profiling and bioinformatics to generate and analyze diagnostics information related to the compound from Janssen.

Skyline will receive R&D funding and is eligible for certain research milestone payments. Further terms of the deal were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.